22.29
Caredx Inc Aktie (CDNA) Neueste Nachrichten
Johnson Fistel has Commenced an Investigation on Behalf of CareDx, Inc. Shareholders - Business Wire
CareDx’s AlloSeq cfDNA Matches AlloSure Test Performance By Investing.com - Investing.com Nigeria
CareDx (CDNA) to Release Earnings on Wednesday - MarketBeat
CareDx, Inc. Announces Study Showing Alloseq cfDNA Highly Accurate in Detecting Rejection in Organ Transplant Patients - Marketscreener.com
CareDx's AlloSeq cfDNA Matches AlloSure Test Performance By Investing.com - Investing.com South Africa
CareDx's AlloSeq cfDNA Matches AlloSure Test Performance - Investing.com
CareDx Announces Study Showing AlloSeq cfDNA Highly Accurate in Detecting Rejection in Organ Transplant Patients - News Hub
Revolutionary Transplant Detection Test Matches Gold Standard in 580-Patient Study - StockTitan
Allspring Global Investments Holdings LLC Raises Stock Holdings in CareDx, Inc (NASDAQ:CDNA) - MarketBeat
StockNews.com Downgrades CareDx (NASDAQ:CDNA) to Hold - MarketBeat
CareDX, Inc. Sued for Securities Law Violations; Investors Should Contact Block & Leviton for More Information - ACCESS Newswire
CareDx (NASDAQ:CDNA) Trading Down 5.5%Time to Sell? - MarketBeat
CareDx, Inc (NASDAQ:CDNA) Shares Sold by Sumitomo Mitsui Trust Group Inc. - MarketBeat
CareDx (NASDAQ:CDNA) Sees Large Volume IncreaseStill a Buy? - MarketBeat
A company insider recently sold 3,512 shares of Caredx Inc [CDNA]. Should You Sale? - Knox Daily
Exploring Three High Growth Tech Stocks In The United States - Yahoo Finance
CareDx’s AlloHeme Shows Accuracy in Detecting Relapse Following AlloHSCT in AML and MDS - CGTLive™
Caredx Inc (CDNA) expanding its growth trajectory ahead - SETE News
Revolutionary Cancer Detection: CareDx Study Reveals 36-Day Early Warning System for Leukemia Relapse - StockTitan
CAREDX SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against CareDx, Inc.CDNA - ACCESS Newswire
CareDx (CDNA) Soars 11.2%: Is Further Upside Left in the Stock? - MSN
Market Momentum: Caredx Inc (CDNA) Registers a -8.43 Decrease, Closing at 22.81 - The Dwinnex
Investing in CareDx (NASDAQ:CDNA) a year ago would have delivered you a 187% gain - Yahoo Finance
CareDx (NASDAQ:CDNA) Trading Down 5.5% – Here’s Why - Defense World
Caredx Inc [CDNA] Stock sold by Insider Novack Jeffrey Adam for $81829.0 - Knox Daily
CareDx to Report Fourth Quarter and Full Year 2024 Financial Results - The Bakersfield Californian
Calamos Advisors LLC Cuts Stock Holdings in CareDx, Inc (NASDAQ:CDNA) - MarketBeat
Adversity is less terrifying than hope: Caredx Inc (CDNA) - SETE News
Market Insights: Caredx Inc (CDNA)’s Notable Gain of 2.12, Closing at 23.59 - The Dwinnex
Does CareDx (CDNA) Have the Potential to Rally 42.25% as Wall Street Analysts Expect? - Yahoo Finance
Did Caredx Inc (CDNA) perform well in the last session? - US Post News
Wells Fargo upgrades Caredx Inc (CDNA) stock to an Equal weight - Knox Daily
Brokerages Set CareDx, Inc (NASDAQ:CDNA) Price Target at $28.33 - MarketBeat
SG Americas Securities LLC Purchases 5,706 Shares of CareDx, Inc (NASDAQ:CDNA) - Defense World
CareDx, Inc (NASDAQ:CDNA): Are Analysts Optimistic? - Simply Wall St
CareDx, Inc (NASDAQ:CDNA) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
Vanguard Group Inc. Increases Stake in CareDx Inc. - GuruFocus.com
Is CareDx (CDNA) Outperforming Other Medical Stocks This Year? - Yahoo Finance
CareDx (CDNA) Traded Down Due to Disappointing Quarterly Results - MSN
CareDx (NASDAQ:CDNA) Trading Down 5.4%Should You Sell? - MarketBeat
Here’s Why CareDx (CDNA) Traded Lower in Q4 - Insider Monkey
Leidos teams with CareDx to transform the Organ Procurement and Transplantation Network - Leidos
Best Momentum Stocks to Buy for January 21st - Yahoo Finance
Wells Fargo upgrades CareDx after a 30% pullback in stock - MSN
CareDx, Inc (NASDAQ:CDNA) Sees Significant Growth in Short Interest - MarketBeat
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):